October 21, 2014
PHILADELPHIA — Metabolic syndrome and other cardiac disorders were prevalent among a population of pediatric liver transplant recipients, according to data presented at the ACG Annual Scientific Meeting.
“The pediatric liver transplant population is an evolving population,” Shankar Baskar, MD, Cleveland Clinic Foundation, Ohio, told Healio.com/Hepatology. “We have really good survival data on them and 85% of them survive through the first 5 years. This population will go into adulthood and as we already know, the adult population, especially with liver transplant, have a lot of cardiovascular morbidity and mortality.”